CML-Cardio: a cascade machine learning model to predict cardiovascular disease risk as a primary prevention strategy

被引:1
|
作者
Oliveira, Bruno Alberto Soares [1 ]
Castro, Giulia Zanon [1 ]
Ferreira, Giovanna Luiza Medina [2 ]
Guimaraes, Frederico Gadelha [1 ]
机构
[1] Univ Fed Minas Gerais, Grad Program Elect Engn, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil
[2] Univ Itauna, Fac Med, Rodovia MG 431 km 45, BR-35680142 Itauna, MG, Brazil
关键词
Cardiovascular diseases; Machine learning; Primary prevention; Explainable artificial intelligence; Healthcare; Anomaly detection; BRAZILIAN GUIDELINES; MANAGEMENT; DIAGNOSIS; SCORE;
D O I
10.1007/s11517-022-02757-z
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Cardiovascular diseases are among the leading causes of mortality worldwide, with more than 23 million related deaths per year by 2030, according to the World Heart Federation. Although most of these diseases may be prevented, population awareness strategies are still ineffective. In this context, we propose the CML-Cardio tool, a machine learning application to automate the risk classification process of developing CVDs. For this, researchers in our group collected data on diabetes, blood pressure, and other risk factors in a private company. Our final model consists of a cascade system to handle highly imbalanced data. In the first stage, a binary model is responsible for predicting whether a patient has a low risk of developing CVDs or if has a risk that needs attention. In this step, we use six algorithms: logistic regression, SVM, random forest, XGBoost, CatBoost, and multilayer perceptron. The better results presented an average accuracy of 0.86 +/- 0.03 and f-score of 0.85 +/- 0.04. We interpret each feature's impact on the models' output and validate the subsystem for the next step. In the second stage, we use an anomaly detection model to learn the intermediate risk patterns present in the instances that need attention. The cascade model presented an average accuracy of 0.80 +/- 0.07 and f-score of 0.70 +/- 0.07. Finally, we develop the CML-Cardio prototype of an actual application as a primary prevention strategy.{Graphical abstract}
引用
收藏
页码:1409 / 1425
页数:17
相关论文
共 50 条
  • [31] A MACHINE LEARNING APPROACH FOR THE IDENTIFICATION OF RISK FACTORS FOR CARDIOVASCULAR DISEASE
    Coelho, J. R.
    Gaspar, I. M.
    Silva, A. M.
    Freitas, A. T.
    CARDIOLOGY, 2013, 126 : 272 - 272
  • [32] Risk prediction of cardiovascular disease using machine learning classifiers
    Pal, Madhumita
    Parija, Smita
    Panda, Ganapati
    Dhama, Kuldeep
    Mohapatra, Ranjan K.
    OPEN MEDICINE, 2022, 17 (01): : 1100 - 1113
  • [33] Machine learning framework for atherosclerotic cardiovascular disease risk assessment
    Parya Esmaeili
    Neda Roshanravan
    Saeid Mousavi
    Samad Ghaffari
    Naimeh Mesri Alamdari
    Mohammad Asghari-Jafarabadi
    Journal of Diabetes & Metabolic Disorders, 2023, 22 : 423 - 430
  • [34] Machine learning framework for atherosclerotic cardiovascular disease risk assessment
    Esmaeili, Parya
    Roshanravan, Neda
    Mousavi, Saeid
    Ghaffari, Samad
    Alamdari, Naimeh Mesri
    Asghari-Jafarabadi, Mohammad
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 22 (01) : 423 - 430
  • [35] An evolutionary machine learning algorithm for cardiovascular disease risk prediction
    Ordikhani, Mohammad
    Abadeh, Mohammad Saniee
    Prugger, Christof
    Hassannejad, Razieh
    Mohammadifard, Noushin
    Sarrafzadegan, Nizal
    PLOS ONE, 2022, 17 (07):
  • [36] Implementation of Machine Learning Model to Predict Heart Failure Disease
    Alotaibi, Fahd Saleh
    INTERNATIONAL JOURNAL OF ADVANCED COMPUTER SCIENCE AND APPLICATIONS, 2019, 10 (06) : 261 - 268
  • [37] Machine learning-based risk prediction model for cardiovascular disease using a hybrid dataset
    Kanagarathinam, Karthick
    Sankaran, Durairaj
    Manikandan, R.
    DATA & KNOWLEDGE ENGINEERING, 2022, 140
  • [38] Primary prevention of cardiovascular disease: global cardiovascular risk assessment and management in clinical practice
    Law, Tamryn K.
    Yan, Andrew T.
    Gupta, Aanika
    Kajil, Mahesh
    Tsigoulis, Michelle
    Singh, Narendra
    Verma, Subodh
    Gupta, Milan
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2015, 1 (01) : 31 - 36
  • [39] Risk scores for primary prevention of cardiovascular disease: Refinement and evaluation required
    Brindle, P
    Beswick, A
    HEART, 2005, 91 : A42 - A42
  • [40] Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury
    Coste, Joel
    Karras, Alexandre
    Rudnichi, Annie
    Dray-Spira, Rosemary
    Pouchot, Jacques
    Giral, Philippe
    Zureik, Mahmoud
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (12) : 1583 - 1590